0001493152-20-004768 Sample Contracts

AMENDMENT NO. 1 TO

Material Transfer and Research Agreement • March 26th, 2020 • AIM ImmunoTech Inc. • Biological products, (no disgnostic substances) • New York

• Contract Type
  Material Transfer and Research Agreement
• Filed
  March 26th, 2020
• Company
  AIM ImmunoTech Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

This First Amendment to the Material Transfer and Research Agreement (the “Agreement”) dated July 11, 2017, by and between AIM ImmunoTech Inc. (“AIM”), formerly Hemispherx Biopharma, Inc., and ROSWELL PARK CANCER INSTITUTE (“INSTITUTE”), who are each a “Party” and together the “Parties” to the Agreement, is entered into as of March 20, 2020 (the “Amendment No. l Effective Date”).